Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals

Neuropsychobiology

Volumn 61, Issue 1, 2009, Pages 27-32

  Mulder, Erik J ^a   Anderson, George M ^b   Kemperman, Ramses F J ^a   Oosterloo Duinkerken, Alida ^a   Minderaa, Ruud B ^a   Kema, Ido P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 Hydroxyindoleacetic acid; Autism; Gut; Melatonin; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 6 HYDROXYMELATONIN O SULFATE; MELATONIN; SEROTONIN;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ADOLESCENT; ADULT; ARTICLE; AUTISM; CATABOLISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HORMONE SYNTHESIS; HUMAN; HYPERSEROTONEMIA; MALE; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; PRIORITY JOURNAL; SCHOOL CHILD; SEROTONIN BLOOD LEVEL; SEROTONIN METABOLISM; THROMBOCYTE; URINARY EXCRETION;

ADOLESCENT; AGE FACTORS; AUTISTIC DISORDER; CREATININE; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MELATONIN; SEROTONIN; TRYPTOPHAN;

EID: 70449644954     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000258640     Document Type: Article

References (33)

1. Grahame-Smith DG: Serotonin (5-hydroxytryptamine, 5-HT). Q J Med 1988; 67: 459-466.
2. Anderson GM: Genetics of Childhood Disorders: XLV. Autism, part 4: serotonin in autism. J Am Acad Child Adolesc Psychiatry 2002; 41: 1513-1516.
3. Cook EH Jr, Leventhal BL: The serotonin system in autism. Curr Opin Pediatr 1996; 8: 348-354.
4. Mulder EJ, Anderson GM, Kema IP, de Bildt A, van Lang ND, den Boer JA, Minderaa RB: Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. J Am Acad Child Adolesc Psychiatry 2004; 43: 491-499.
5. Gershon MD: Plasticity in serotonin control mechanisms in the gut. Curr Opin Pharmacol 2003; 3: 600-607.
6. Anderson GM, Stevenson JM, Cohen DJ: Steady-state model for plasma free and platelet serotonin in man. Life Sci 1987; 41: 1777-1785.
7. Kema IP, De Vries EG, Muskiet FA: Clinical chemistry of serotonin and metabolites. J Chromatogr B Biomed Sci Appl 2000; 747: 33-48.
8. Schain RJ, Freedman DX: Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 1961; 58: 315-320.
9. Partington MW, Tu JB, Wong CY: Blood serotonin levels in severe mental retardation. Dev Med Child Neurol 1973; 15: 616-627.
10. Minderaa RB, Anderson GM, Volkmar FR, Akkerhuis GW, Cohen DJ: Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects. Biol Psychiatry 1987; 22: 933-940.
11. Launay JM, Ferrari P, Haimart M, Bursztejn C, Tabuteau F, Braconnier A, Pasques-Bondoux D, Luong C, Dreux C: Serotonin metabolism and other biochemical parameters in infantile autism: a controlled study of 22 autistic children. Neuropsychobiology 1988; 20: 1-11.
12. Martineau J, Barthelemy C, Jouve J, Muh JP, Lelord G: Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects. Dev Med Child Neurol 1992; 34: 593-603.
13. Herault J, Petit E, Martineau J, Cherpi C, Perrot A, Barthelemy C, Lelord G, Muh JP: Serotonin and autism: biochemical and molecular biology features. Psychiatry Res 1996; 65: 33-43.
14. Croonenberghs J, Delmeire L, Verkerk R, Lin AH, Meskal A, Neels H, Van der PM, Scharpe S, Deboutte D, Pison G, Maes M: Peripheral markers of serotonergic and noradrenergic function in post-pubertal, Caucasian males with autistic disorder. Neuropsychopharmacology 2000; 22: 275-283.
15. Hanley HG, Stahl SM, Freedman DX: Hyperserotonemia and amine metabolites in autistic and retarded children. Arch Gen Psychiatry 1977; 34: 521-531.
16. Anderson GM, Minderaa RB, Cho SC, Volkmar FR, Cohen DJ: The issue of hyperserotonemia and platelet serotonin exposure: a preliminary study. J Autism Dev Disord 1989; 19: 349-351.
17. Brzezinski A: Melatonin in humans. N Engl J Med 1997; 336: 186-195.
18. Bubenik GA: Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47: 2336-2348.
19. Lynch HJ, Wurtman RJ, Moskowitz MA, Archer MC, Ho MH: Daily rhythm in human urinary melatonin. Science 1975; 187: 169-171.
20. Ritvo ER, Ritvo R, Yuwiler A, Brothers A, Freeman BJ, Plotkin S: Elevated daytime melatonin concentrations in autism: a pilot study. Eur Child Adolesc Psychiatry 1993; 2: 75-78.
21. Nir I, Meir D, Zilber N, Knobler H, Hadjez J, Lerner Y: Brief report: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev Disord 1995; 25: 641-654.
22. Kulman G, Lissoni P, Rovelli F, Roselli MG, Brivio F, Sequeri P: Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol Lett 2000; 21: 31-34.
23. Tordjman S, Anderson GM, Pichard N, Charbuy H, Touitou Y: Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol Psychiatry 2005; 57: 134-138.
24. Melke J, Goubran BH, Chaste P, Betancur C, Nygren G, Anckarsater H, Rastam M, Stahlberg O, Gillberg IC, Delorme R, Chabane N, Mouren-Simeoni MC, Fauchereau F, Durand CM, Chevalier F, Drouot X, Collet C, Launay JM, Leboyer M, Gillberg C, Bourgeron T: Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry 2008; 13: 90-98. (Pubitemid 350275181)
25. Lord C, Rutter M, Le Couteur A: Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24: 659-685.
26. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, Pickles A, Rutter M: The Autism Diagnostic Observation Schedule-Generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000; 30: 205-223.
27. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, Text Revision. Washington, American Psychiatric Association, 2000.
28. Kema IP, Meijer WG, Meiborg G, Ooms B, Willemse PH, De Vries EG: Profiling of tryptophan- related plasma indoles in patients with carcinoid tumors by automated, online, solid-phase extraction and HPLC with fluorescence detection. Clin Chem 2001; 47: 1811-1820.
29. Kwarts E, Kwarts J, Rutgers H: A simple paired-ion liquid chromatography assay for serotonin in cerebrospinal fluid, plateletrich plasma, serum and urine. Ann Clin Biochem 1984; 21: 425-429.
30. Mulder EJ, Oosterloo-Duinkerken A, Anderson GM, De Vries EG, Minderaa RB, Kema IP: Automated on-line solid-phase extraction coupled with HPLC for measurement of 5-hydroxyindole-3-acetic acid in urine. Clin Chem 2005; 51: 1698-1703.
31. Larsson M, Forsman A, Hallgren J: HPLC assays of 5-HIAA and tryptophan in cerebrospinal fluid and 5-HT and tryptophan in blood: a methodological study with clinical applications. Methods Find Exp Clin Pharmacol 1988; 10: 453-460.
32. Deacon AC: The measurement of 5-hydroxyindoleacetic acid in urine. Ann Clin Biochem 1994; 31: 215-232.
33. Janusonis S: Serotonergic paradoxes of autism replicated in a simple mathematical model. Med Hypotheses 2005; 64: 742-750.